Protagenic Therapeutics, Inc.\new Additional Paid in Capital, Common Stock
Protagenic Therapeutics, Inc.\new (PTIX) had Additional Paid in Capital, Common Stock of $181.46 million as of 2011-09-30, per its 10-Q filed 2011-11-14.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2011-11-14
- 2011-09-30: Additional Paid in Capital, Common Stock $181.46M.
- 2011-06-30: Additional Paid in Capital, Common Stock $181.43M.
- 2010-12-31: Additional Paid in Capital, Common Stock $181.09M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2011-09-30 | $181.46M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $181.43M 10-Q/A · filed 2011-09-07 |
| 2010-12-31 | $181.09M 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |